Authors:
Bracken, MB
Aldrich, EF
Herr, DL
Hitchon, PW
Holford, TR
Marshall, LF
Nockels, RP
Pascale, V
Shepard, MJ
Sonntag, VKH
Winn, HR
Young, W
Citation: Mb. Bracken et al., Clinical measurement, statistical analysis, and risk-benefit: Controversies from trials of spinal injury, J TRAUMA, 48(3), 2000, pp. 558-561
Citation: Lf. Marshall, Limits of intermittent jugular bulb oxygen saturation monitoring in the management of severe head trauma patients - Comment, NEUROSURGER, 46(5), 2000, pp. 1139-1139
Citation: Lf. Marshall, The value of the "worst" computed tomographic scan in clinical studies of moderate and severe head injury - Comment, NEUROSURGER, 46(1), 2000, pp. 77-77
Authors:
Juul, N
Morris, GF
Marshall, SB
Marshall, LF
Citation: N. Juul et al., Intracranial hypertension and cerebral perfusion pressure: Influence on neurological deterioration and outcome in severe head injury, J NEUROSURG, 92(1), 2000, pp. 1-6
Authors:
Maas, AIR
Steyerberg, EW
Murray, GD
Bullock, R
Baethmann, A
Marshall, LF
Teasdale, GM
Citation: Air. Maas et al., Why have recent trials of neuroprotective agents in head injury failed to show convincing efficacy? A pragmatic analysis and theoretical considerations, NEUROSURGER, 44(6), 1999, pp. 1286-1298
Authors:
Ananda, A
Morris, GF
Juul, N
Marshall, SB
Marshall, LF
Citation: A. Ananda et al., The frequency, antecedent events, and causal relationships of neurologic worsening following severe head injury, ACT NEUR S, 73, 1999, pp. 99-102
Authors:
Morris, GF
Bullock, R
Marshall, SB
Marmarou, A
Maas, A
Marshall, LF
Citation: Gf. Morris et al., Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two Phase III clinical trials, J NEUROSURG, 91(5), 1999, pp. 737-743
Authors:
Bracken, MB
Shepard, MJ
Holford, TR
Leo-Summers, L
Aldrich, EF
Fazl, M
Fehlings, MG
Herr, DL
Hitchon, PW
Marshall, LF
Nockels, RP
Pascale, V
Perot, PL
Piepmeier, J
Sonntag, VKH
Wagner, F
Wilberger, JE
Winn, HR
Young, W
Citation: Mb. Bracken et al., Methylprednisolone or tirilazad mesylate administration after acute spinalcord injury: 1-year follow up - Results of the third National Acute SpinalCord Injury randomized controlled trial, J NEUROSURG, 89(5), 1998, pp. 699-706